FIELD: medicine, pharmacy.
SUBSTANCE: group of inventions refers to medicine, namely to ophthalmology, and is intended for treatment of allergic eye conjunctivitis. Ophthalmic composition for treatment of allergic eye conjunctivitis comprises at least 0.67% wt/vol, but not more than 1.0% wt/vol of olopatadine which is dissolved in the solution. The composition is placed in an eye drop dispenser for drop application of composition into the eye with droplets size of at least 18 mcl, but not more than 45 mcl. The composition has a pH from 5.5 to 8.0. Additionally, the composition comprises polyethylene glycol, polyvinylpyrrolidone and the cyclodextrin derivative in the stated amounts. Also a method of symptoms of eye allergy symptoms treatment is provided.
EFFECT: invention allows more effective reduction of allergic eyenconjunctivitis symptoms, especially the symptoms of late-phase allergic eye conjunctivitis.
25 cl, 5 dwg, 20 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES | 2009 |
|
RU2477631C2 |
| AQUEOUS PHARMACEUTICAL COMPOSITIONS, CONTAINING BORATE-POLYOL COMPLEXES | 2010 |
|
RU2563125C2 |
| ANDROGEN COMPOSITION FOR TREATING OPHTHALMIC CONDITIONS | 2012 |
|
RU2599036C2 |
| OPHTHALMIC COMPOSITIONS FOR DRUG DELIVERY AND EYE ANTERIOR SEGMENT | 2015 |
|
RU2704810C2 |
| OPHTHALMIC FORMULATIONS FOR DRUG DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE | 2014 |
|
RU2768489C2 |
| OPHTHALMIC FORMULATIONS FOR DRUG DELIVERY AND ANTERIOR EYE PROTECTION | 2015 |
|
RU2768652C1 |
| LOW-DOSE BRIMONIDINE COMBINATIONS AND THEIR USE | 2018 |
|
RU2801221C2 |
| OCULAR COMPOSITIONS FOR DRUG-DELIVERY TO POSTERIOR SEGMENT OF THE EYE | 2014 |
|
RU2665953C2 |
| SELF-PRESERVED WATER PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2436568C2 |
| METHODS AND COMPOSITIONS FOR TREATING PRESBYOPIA, MYDRIASIS AND OTHER OCULAR DISORDERS | 2019 |
|
RU2824137C2 |
